Devices, systems, and methods for real-time monitoring of electrophysical effects during tissue treatment

Patent metadata

Field	Value
Publication number	US-10694972-B2
Application number	US-201515536333-A
Country	US
Kind code	B2
Filing date	Dec 15, 2015
Priority date	Dec 15, 2014
Publication date	Jun 30, 2020
Grant date	Jun 30, 2020

Abstract

Provided herein are devices, systems, and methods for monitoring lesion or treated area in a tissue during focal ablation or cell membrane disruption therapy. Provided herein are embodiments of an electrical conductivity sensor having an impedance sensor, where the impedance sensor can be configured to measure a low-frequency and a high-frequency impedance and a substrate, where the impedance sensor is coupled to the substrate. The substrate can be flexible. In embodiments, the impedance sensor can contain two or more electrical conductors. The electrical conductors can be in a bipolar configuration. The electrical conductors can be in a tetrapolar configuration. In embodiments, the electrical conductivity sensor can have two impedance sensors that can be coupled to the substrate such that they are orthogonal to each other.

First claim

We claim:

1. A system comprising:
an electrical conductivity probe, wherein the electrical conductivity probe comprises:
an elongated member;
an electrical conductivity sensor comprising;
an impedance sensor, where the impedance sensor is configured to measure a low-frequency and a high-frequency impedance; and
a substrate, where the impedance sensor is coupled to the substrate, wherein the electrical conductivity sensor is removably coupled to the elongated member;

a treatment probe configured to deliver an energy to a tissue, where the energy is sufficient to disrupt a cell membrane;
an impedance analyzer, where the impedance analyzer is coupled to the electrical conductivity probe;
a low voltage power supply, where the low voltage power supply is coupled to the electrical conductivity probe and is configured to deliver a low voltage energy to the electrical conductivity probe;
a waveform generator, where the waveform generator is coupled to the low voltage power supply;
a gate driver, where the gate driver is coupled to the waveform generator and the low voltage power supply;
a high voltage switch, where the high voltage switch is coupled to the treatment probe and the impedance analyzer; and
a high voltage power supply, where the high voltage power supply is coupled to the high voltage switch.

2. The system of claim 1 , further comprising a computer, wherein the computer is coupled to the impedance analyzer and wherein the computer comprises processing logic configured to determine a position of a lesion or treated area front within a tissue undergoing focal ablation/cell membrane disruption therapy.

3. The system of claim 2 , wherein the processing logic is further configured to generate a signal to a user when the position of the lesion or treated area front has reached a predetermined position within the tissue.

4. The system of claim 2 , wherein the processing logic is further configured to automatically manipulate the system to adjust or stop treatment of the tissue by the treatment probe when the position of the lesion or treated area front has reached a predetermined position within the tissue.

5. The system of claim 2 , wherein the treatment probe is coupled with a grounding pad configured to be located elsewhere in or on a body of a subject being treated.

6. The system of claim 1 , wherein the treatment probe and the electrical conductivity probe are probe regions on the same probe.

7. A method of monitoring a lesion, a treated area front, or a size thereof during focal ablation or cell membrane disruption therapy, the method comprising:
inserting the electrical conductivity probe of the system of claim 1 , into a tissue;
inserting the treatment probe of the system of claim 1 , into the tissue;
applying a treatment to the tissue, wherein the treatment comprises applying said energy to the tissue via the treatment probe;
measuring a characteristic of the tissue continuously during the treatment; and
detecting a change in the tissue characteristic;
wherein the electrical conductivity probe comprises an impedance sensor array comprising two or more impedance sensors, said two or more impedance sensors include said impedance sensor, and further comprising the step of determining the location of the lesion, or the treated area front or the size thereof by comparing impedance data between the two or more impedance sensors of the impedance sensor array.

8. The method of claim 7 , wherein the tissue characteristic is impedance.

9. The method of claim 7 , wherein the step of measuring comprises measuring both low-frequency impedance and high-frequency impedance and further comprising, determining that the low-frequency impedance is equal to the high frequency impedance; and further comprising the step of stopping the treatment.

10. The method of claim 7 , wherein the tissue characteristic is pH, temperature, a gas concentration, a chemical concentration, a nucleic acid concentration, or a combination thereof.

11. The method of claim 7 , wherein the change in the tissue characteristic is detected and further comprising the step of stopping the applied treatment.

12. The method of claim 7 , wherein the change in the tissue characteristic is detected and further comprising the step of alerting a user of the detected change in the tissue characteristic.

13. The method of claim 7 , further comprising the step of comparing the lesion or the treated area front, or size thereof to a threshold value and stopping the applied treatment when the lesion or the treated area front or size is greater than or equal to the threshold value.

14. The method of claim 7 , further comprising the step of comparing the lesion or the treated area front, or size thereof to a threshold value and alerting a user when the lesion or the treated area front or size is greater than or equal to the threshold value.

15. The method of claim 7 , further comprising the steps of comparing measured changes in impedance to a solution for an electric field distribution during focal ablation or cell membrane disruption and determining a 2D/3D lesion or a 2D/3D treated area geometry of the lesion or the treated area front.

16. The method of claim 15 , further comprising the step of overlaying the 2D/3D lesion or treated area geometry on one or more medical images of a subject to generate an image overlay.

17. The method of claim 16 , further comprising the step of visualizing migration, growth, or both of the lesion or the treatment area front from the image overlay.

Assignees

• Virginia Tech Intellectual Properties Inc

Inventors

• Davalos Rafael V
• Bonakdar Mohammad
• Latouche Eduardo L
• Mahajan Roop L
• Robertson John L
• Arena Christopher B
• Sano Michael B

Classifications

• A61B5/0538 Primary

  invasively, e.g. using a catheter · CPC title

• G01N33/5438

  Electrodes · CPC title

• A61B5/01

  Measuring temperature of body parts {; Diagnostic temperature sensing, e.g. for malignant or inflamed tissue} (clinical contact thermometers G01K13/20) · CPC title